0.5374

14.78% -0.0932

VolitionRX Ltd (VNRX)

Overview News Price History Option Chain Discussions Forecast

VolitionRX Ltd stock is traded at $0.5374, with a volume of 952.43K. It is down -14.78% in the last 24 hours and down -57.69% over the past month. VolitionRX Limited, a life sciences company, engages in the development of blood tests to help diagnose a range of cancers worldwide. The company develops 39 epigenetic Nu.Q blood assays based on its Nucleosomics biomarker discovery platform. VolitionRX Limited is based in Singapore.

Previous Close:

$0.6306

Open:

$0.62

24h Volume:

952.43K

Relative Volume:

1.93

Market Cap:

$6.47M

Revenue:

$2.47M

Net Income/Loss:

$-24.73M

P/E Ratio:

-0.1276

EPS:

-4.213

Net Cash Flow:

$-20.36M

1W Performance:

-30.68%

1M Performance:

-57.69%

6M Performance:

-88.15%

1Y Performance:

-95.83%

1-Day Range:

$0.53

$0.63

1-Week Range:

$0.53

$0.7935

52-Week Range:

$0.53

$15.10

VolitionRX Ltd Stock (VNRX) Company Profile

Name

VolitionRX Ltd

Sector

Healthcare (1080)

Industry

Diagnostics & Research (50)

Phone

646 650 1351

Address

No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX

Employee

Twitter

@VolitionRx

Next Earnings Date

2026-08-13

Latest SEC Filings

VNRX's Discussions on Twitter

Compare VNRX vs TMO, DHR, NTRA, IDXX, A

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VNRX VolitionRX Ltd	0.5374	8.05M	2.47M	-24.73M	-20.36M	-4.213
TMO Thermo Fisher Scientific Inc	588.29	222.96B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	202.45	144.67B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	309.93	45.54B	2.50B	-226.32M	71.51M	-1.6412
IDXX Idexx Laboratories Inc	550.96	44.95B	4.45B	1.10B	1.06B	13.59
A Agilent Technologies Inc	148.53	41.87B	7.23B	1.41B	1.09B	4.979

VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-08-25	Initiated	H.C. Wainwright	Buy
Feb-01-23	Downgrade	The Benchmark Company	Buy → Hold
Feb-17-22	Resumed	Cantor Fitzgerald	Overweight
Mar-10-21	Initiated	Cantor Fitzgerald	Overweight
May-16-18	Initiated	Maxim Group	Buy
May-14-18	Reiterated	The Benchmark Company	Buy
Sep-07-16	Reiterated	Rodman & Renshaw	Buy
Feb-01-16	Initiated	Rodman & Renshaw	Buy

View All

VolitionRX Ltd Stock (VNRX) Latest News

Aug 14, 2026

Lagoda Investment discloses 14.0% VolitionRX (VNRX) stake in amended Schedule 13G - Stock Titan

Aug 14, 2026

VolitionRx (VNRX) Q2 2026 Ergebniskonferenz: Kosten sinken bei Fortschritten der Nu.Q-Pipeline - TradingKey

Aug 14, 2026

Earnings call transcript: VolitionRX misses Q2 2026 estimates as shares slip - Investing.com

Aug 14, 2026

VolitionRX Reports Q2 2026 Results: Full Earnings Call Transcript - benzinga.com

Aug 14, 2026

VolitionRx Limited Q2 2026 Earnings Call Summary - Yahoo Finance

Aug 14, 2026

Volitionrx Ltd earnings beat by $0.06, revenue fell short of estimates - Investing.com South Africa

Aug 14, 2026

VolitionRx Q2 Revenue Flat, but Licensing Talks and $5M Milestone Ahead - Minichart

Aug 14, 2026

Aug 13, 2026

VolitionRx (VNRX) flags going concern risk amid $14M loss and NYSE plan - Stock Titan

Aug 13, 2026

VolitionRx Limited (NYSE: VNRX) doubles H1 2026 revenue and trims losses - Stock Titan

Aug 13, 2026

VolitionRx Limited、2026年第2四半期の財務結果および事業状況を発表 - Moomoo

Aug 13, 2026

Earnings To Watch: VolitionRX Ltd (VNRX) Q2 2026 -- GF Value Sees 3914% Upside - Yahoo Finance

Aug 13, 2026

Aug 12, 2026

VolitionRx Limited (VNRX) stock price, news, quote and history - Yahoo Finance UK

Aug 12, 2026

VolitionRx tests finger-prick sepsis prototype in patients - Investing.com Nigeria

Aug 12, 2026

VolitionRx tests finger-prick sepsis prototype in patients By Investing.com - Investing.com Australia

Aug 12, 2026

VolitionRx Limited Demonstrates Utility of Rapid Point-Of-Care Finger-Prick Test in Sepsis Patients - marketscreener.com

Aug 12, 2026

Aug 11, 2026

VolitionRx call will cover Q2 results and upcoming milestones - Stock Titan

Aug 11, 2026

Aug 10, 2026

5 Stocks To BUY HEAVY In Early August 2026 Cat Deeley (ii210v0TXj) - Mshale

Aug 10, 2026

Aug 09, 2026